These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36253562)

  • 1. Surface Characterization as a Tool for Identifying the Factors Affecting the Dissolution Rate of Amorphous Solid Dispersion Tablets.
    Yu D; Fiddler F; Ibrahim A; Sanedrin R; Tremblay H; Hoag SW
    AAPS PharmSciTech; 2022 Oct; 23(8):282. PubMed ID: 36253562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive evaluation of polymer types and ratios in Spray-Dried Dispersions: Compaction, Dissolution, and physical stability.
    Yu D; Nie H; Hoag SW
    Int J Pharm; 2024 Jan; 650():123674. PubMed ID: 38061497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of diluents on the compaction, dissolution, and physical stability of amorphous solid dispersion tablets.
    Yu D; Hoag SW
    Int J Pharm; 2024 Apr; 654():123924. PubMed ID: 38395318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of Films to Anticipate Effect of Drug Load and Polymer on Dissolution Performance from Tablets of Amorphous Itraconazole Spray-Dried Dispersions.
    Honick M; Sarpal K; Alayoubi A; Zidan A; Hoag SW; Hollenbeck RG; Munson EJ; Polli JE
    AAPS PharmSciTech; 2019 Nov; 20(8):331. PubMed ID: 31677012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generality of Enhancing the Dissolution Rates of Free Acid Amorphous Solid Dispersions by the Incorporation of Sodium Hydroxide.
    Zhang HJ; Chiang CW; Maschmeyer-Tombs T; Conklin B; Napolitano JG; Lubach JW; Nagapudi K; Mao C; Chen Y
    Mol Pharm; 2024 Jul; 21(7):3395-3406. PubMed ID: 38836777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of polymer type, ASD loading and polymer-drug ratio on ASD tablet disintegration and drug release.
    Zhang W; Noland R; Chin S; Petkovic M; Zuniga R; Santarra B; Conklin B; Hou HH; Nagapudi K; Gruenhagen JA; Yehl P; Chen T
    Int J Pharm; 2021 Jan; 592():120087. PubMed ID: 33189812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulating Amorphous Solid Dispersions: Impact of Inorganic Salts on Drug Release from Tablets Containing Itraconazole-HPMC Extrudate.
    Takano R; Maurer R; Jacob L; Stowasser F; Stillhart C; Page S
    Mol Pharm; 2020 Aug; 17(8):2768-2778. PubMed ID: 31794228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of drug loading on the compaction properties of itraconazole-PVPVA amorphous solid dispersions.
    Zhang W; Sluga KK; Yost E; Phan J; Nagapudi K; Helen Hou H
    Int J Pharm; 2022 Dec; 629():122366. PubMed ID: 36336201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Surfactants on Itraconazole-Hydroxypropyl Methylcellulose Acetate Succinate Solid Dispersion Prepared by Hot Melt Extrusion III: Tableting of Extrudates and Drug Release From Tablets.
    Solanki NG; Kathawala M; Serajuddin ATM
    J Pharm Sci; 2019 Dec; 108(12):3859-3869. PubMed ID: 31542437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congruent Release of Drug and Polymer from Amorphous Solid Dispersions: Insights into the Role of Drug-Polymer Hydrogen Bonding, Surface Crystallization, and Glass Transition.
    Saboo S; Kestur US; Flaherty DP; Taylor LS
    Mol Pharm; 2020 Apr; 17(4):1261-1275. PubMed ID: 32134677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ternary Amorphous Solid Dispersions Containing a High-Viscosity Polymer and Mesoporous Silica Enhance Dissolution Performance†.
    Hanada M; Jermain SV; Thompson SA; Furuta H; Fukuda M; Williams RO
    Mol Pharm; 2021 Jan; 18(1):198-213. PubMed ID: 33291881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of tablet formulation and subsequent film coating on the supersaturated dissolution behavior of amorphous solid dispersions.
    Sakai T; Hirai D; Kimura SI; Iwao Y; Itai S
    Int J Pharm; 2018 Apr; 540(1-2):171-177. PubMed ID: 29447848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel High-Drug-Loaded Amorphous Dispersion Tablets of Posaconazole;
    Mudie DM; Stewart AM; Biswas N; Brodeur TJ; Shepard KB; Smith A; Morgen MM; Baumann JM; Vodak DT
    Mol Pharm; 2020 Dec; 17(12):4463-4472. PubMed ID: 32835489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Surfactants on Itraconazole-HPMCAS Solid Dispersion Prepared by Hot-Melt Extrusion I: Miscibility and Drug Release.
    Solanki NG; Lam K; Tahsin M; Gumaste SG; Shah AV; Serajuddin ATM
    J Pharm Sci; 2019 Apr; 108(4):1453-1465. PubMed ID: 30395834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concordance of vacuum compression molding with spray drying in screening of amorphous solid dispersions of itraconazole.
    Dhumal G; Treffer D; Polli JE
    Int J Pharm; 2024 Apr; 654():123952. PubMed ID: 38417729
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Jermain SV; Lowinger MB; Ellenberger DJ; Miller DA; Su Y; Williams RO
    Mol Pharm; 2020 Aug; 17(8):2789-2808. PubMed ID: 32520562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidating the effect of crystallization on drug release from amorphous solid dispersions in soluble and insoluble carriers.
    Ojo AT; Ma C; Lee PI
    Int J Pharm; 2020 Dec; 591():120005. PubMed ID: 33132149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the Release Mechanisms of ITZ:HPMCAS Amorphous Solid Dispersions: The Role of Drug-Rich Colloids.
    Nunes PD; Pinto JF; Henriques J; Paiva AM
    Mol Pharm; 2022 Jan; 19(1):51-66. PubMed ID: 34919407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congruent release of drug and polymer: A "sweet spot" in the dissolution of amorphous solid dispersions.
    Saboo S; Mugheirbi NA; Zemlyanov DY; Kestur US; Taylor LS
    J Control Release; 2019 Mar; 298():68-82. PubMed ID: 30731151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.